Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with uterine cancer (endometrial carcinoma), confirmed by a tissue test, at stages I to III
- Your cancer is either the common type (endometrioid) or a less common type (non-endometrioid) of uterine cancer
- You are well enough to have surgery, with a general health score of 70 or above on a standard medical scale (confirm with trial site)
- You are 18 years of age or older
- You have completed treatment either through a specific surgical approach used in this trial (called Cohort A), or through standard treatment following established European guidelines (called Cohort B)
- You are willing and able to give your informed consent to take part
Who may not be able to join:
- Your uterine cancer is a pure sarcoma (a specific type that starts in muscle or connective tissue)
- Your cancer has spread to distant parts of the body (distant metastases)
- You have certain connective tissue diseases, such as scleroderma, lupus, or mixed connective tissue disease
- You have or have had another separate cancer
- You have previously had radiotherapy (radiation treatment) to the pelvis
- You are pregnant
- You received radiotherapy after surgery, unless it was given specifically because cancer cells were left behind after surgery or five or more lymph nodes were affected — in those cases, joining the Cohort A group may still be possible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rainer Kimmig, Prof., University Hospital, Essen
Phone: +492017232442
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression Free Survival; Intra- and postoperative complications, incidence of lymph oedema
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.